Correlation Between Olema Pharmaceuticals and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both Olema Pharmaceuticals and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Olema Pharmaceuticals and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Olema Pharmaceuticals and Cullinan Oncology LLC, you can compare the effects of market volatilities on Olema Pharmaceuticals and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Olema Pharmaceuticals with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Olema Pharmaceuticals and Cullinan Oncology.
Diversification Opportunities for Olema Pharmaceuticals and Cullinan Oncology
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Olema and Cullinan is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Olema Pharmaceuticals and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Olema Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Olema Pharmaceuticals are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Olema Pharmaceuticals i.e., Olema Pharmaceuticals and Cullinan Oncology go up and down completely randomly.
Pair Corralation between Olema Pharmaceuticals and Cullinan Oncology
Given the investment horizon of 90 days Olema Pharmaceuticals is expected to generate 1.13 times more return on investment than Cullinan Oncology. However, Olema Pharmaceuticals is 1.13 times more volatile than Cullinan Oncology LLC. It trades about -0.02 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about -0.12 per unit of risk. If you would invest 1,135 in Olema Pharmaceuticals on September 2, 2024 and sell it today you would lose (123.00) from holding Olema Pharmaceuticals or give up 10.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Olema Pharmaceuticals vs. Cullinan Oncology LLC
Performance |
| Timeline |
| Olema Pharmaceuticals |
| Cullinan Oncology LLC |
Olema Pharmaceuticals and Cullinan Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Olema Pharmaceuticals and Cullinan Oncology
The main advantage of trading using opposite Olema Pharmaceuticals and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Olema Pharmaceuticals position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.| Olema Pharmaceuticals vs. Sana Biotechnology | Olema Pharmaceuticals vs. Cullinan Oncology LLC | Olema Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Olema Pharmaceuticals vs. Molecular Partners AG |
| Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |